COMPUTEX-TAIPEI
28.5.2021 10:51:07 CEST | Business Wire | Press release
COMPUTEX 2021 Virtual organized by TAITRA will take place from May 31 to June 30 online. To keep the industry updated with the most groundbreaking technology trends and provide participants with a comprehensive vision of the world, COMPUTEX extended its keynote and forum speeches to top CEOs and senior executives from leading international companies such as AMD, Arm, Intel, Micron, NVIDIA, NXP Semiconductors, Qualcomm and Supermicro.
James Huang, TAITRA Chairman, pointed out that "COMPUTEX CEO Keynote has received great interest since its introduction in 2019. This year, COMPUTEX takes it a step further by leveraging the cross-industry capabilities of technology giants, providing a platform to share insights and exchange ideas in reshaping a post-pandemic future.”
Leading CEOs and Senior Executives of Tech Giants to Deliver Keynotes
Monday, May 31, at 10:00 AM (GMT+8)
Michelle Johnston Holthaus, Executive Vice President at Intel Corporation, will speak on the Innovation Unleashed
and welcome Intel’s Steve Long, corporate vice president of Client Computing Group Sales, and Lisa Spelman, corporate vice president and general manager of the Xeon and Memory Group, to outline how Intel innovations help expand human potential by expanding technology’s potential.
Monday, May 31, at 2:00 PM (GMT+8)
Arm CEO Simon Segars will give a keynote on Sparking the World’s Post-Pandemic Recovery
, analyzing how AI will accelerate tackling complex challenges surrounding climate change, security, and equitable access to technologies and connectivity, acting thus as a remarkable force for good.
Tuesday, June 1, at 10:00 AM (GMT+8)
Dr. Lisa Su, President and CEO of AMD, will present a keynote with the theme “AMD Accelerating – The High-Performance Computing Ecosystem”
, sharing the AMD vision for the future of computing and how AMD speeds up innovation with ecosystem partners to deliver a leadership product portfolio for innovative solutions.
Tuesday, June 1, at 10:00 AM (GMT+8)
Jeff Fisher, Senior Vice President of NVIDIA’s GeForce Business Unit and Manuvir Das, Head of Enterprise Computing at NVIDIA will discuss The Transformational Power of Accelerated Computing
, from Gaming to the Enterprise Data Center. They will present the massive opportunities that GeForce PC gaming represents for the Taiwan ecosystem and shifts driving the democratization of AI and how enterprises embrace them can thrive in the coming years.
Wednesday, June 2, at 9:00 AM (GMT+8)
Sanjay Mehrotra, President and Chief Executive Officer of Micron will focus his keynote on Innovation for the Data Economy: Why Today’s Infrastructure Innovation Brings Data to Life, Powering Insights for All
, opening for the AIoT Evolution session of the COMPUTEX Forum, and sharing Micron’s vision for how data transform modern life and creates new opportunities for memory and storage innovation.
Wednesday, June 2, 10:30 AM (GMT+8)
Supermicro President, CEO & Chairman of the Board, Charles Liang, will give a keynote on Performance Begins at the Edge for 5G and Intelligent IoT
, presenting Supermicro’s newest solutions as well as its future strategy.
Wednesday, June 2, 2:00 PM (GMT+8)
NXP Semiconductors President and CEO Kurt Sievers will deliver a keynote on How AI Can Empower Industries, IoT and Automotive Industry
, the opening session for the AI Empowerment of the COMPUTEX Forum by sharing NXP Semiconductors' development and plans in AI, broadening people’s imagination of intelligent places.
Thursday, June 3, 8:40 AM (GMT+8)
Qualcomm Senior Vice President and General Manager Alex Katouzian will speak on "5G and the Future of the PC
," where he will share his unique perspectives on how 5G and the Always on, Always Connected PC are shaping the future of computing to meet the needs of a more mobile society.
For more COMPUTEX CEO Keynote and show information, please check out the official COMPUTEX website:
https://virtual.computextaipei.com.tw/events/
For more updates：
COMPUTEX website: https://www.computextaipei.com.tw
InnoVEX website: https://www.innovex.com.tw/
About COMPUTEX TAIPEI (also called COMPUTEX):
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual:
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX, Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnoVEXVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
About TAITRA:
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210528005147/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom